In summary, we verified a new autophagy regulation mechanism involving the SHMT2–p53–HDM2 competitive binding system and confirmed the importance of this mechanism in mediating the response to CRC 5-FU–based chemotherapy. This evidence concerns the gene MDM2 and colorectal carcinoma.